MedTrace Logo

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

NCT04298619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2020-03-06

No results posted yet for this study

Summary

Cohort study enrolled high-risk Hodgkin Lymphoma patients in first relapse after induction therapy followed after remission either with a systemic imaging-based surveillance (Imaging cohort) or with standard clinical-based surveillance (standard cohort).

Conditions

Interventions

DIAGNOSTIC_TEST

Standard cohort: Clinical lab follow-up

DIAGNOSTIC_TEST

Imaging cohort: integrated imaging follow-up

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Primary Completion
2016-04-30
Completion
2019-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04298619 on ClinicalTrials.gov